Annual Interest Expense
$333.60 K
-$101.00 K-23.24%
31 December 2023
Summary:
China Pharma Holdings annual interest expense is currently $333.60 thousand, with the most recent change of -$101.00 thousand (-23.24%) on 31 December 2023. During the last 3 years, it has risen by +$39.40 thousand (+13.39%). CPHI annual interest expense is now -71.37% below its all-time high of $1.17 million, reached on 31 December 2015.CPHI Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Interest Expense
$34.10 K
-$14.00 K-29.11%
30 September 2024
Summary:
China Pharma Holdings quarterly interest expense is currently $34.10 thousand, with the most recent change of -$14.00 thousand (-29.11%) on 30 September 2024. Over the past year, it has dropped by -$32.10 thousand (-48.49%). CPHI quarterly interest expense is now -89.77% below its all-time high of $333.40 thousand, reached on 31 December 2021.CPHI Quarterly Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Interest Expense
$174.70 K
-$32.10 K-15.52%
30 September 2024
Summary:
China Pharma Holdings TTM interest expense is currently $174.70 thousand, with the most recent change of -$32.10 thousand (-15.52%) on 30 September 2024. Over the past year, it has dropped by -$204.80 thousand (-53.97%). CPHI TTM interest expense is now -86.05% below its all-time high of $1.25 million, reached on 30 June 2015.CPHI TTM Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CPHI Interest Expense Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -23.2% | -48.5% | -54.0% |
| 3 y3 years | +13.4% | -47.5% | -44.8% |
| 5 y5 years | -26.1% | -49.6% | -48.9% |
CPHI Interest Expense High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -38.5% | +13.4% | -89.8% | at low | -74.0% | at low |
| 5 y | 5 years | -38.5% | +13.4% | -89.8% | at low | -74.0% | at low |
| alltime | all time | -71.4% | +154.7% | -89.8% | +39.8% | -86.0% | +357.3% |
China Pharma Holdings Interest Expense History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $34.10 K(-29.1%) | $174.70 K(-15.5%) |
| June 2024 | - | $48.10 K(+14.0%) | $206.80 K(-30.2%) |
| Mar 2024 | - | $42.20 K(-16.1%) | $296.40 K(-11.2%) |
| Dec 2023 | $333.60 K(-23.2%) | $50.30 K(-24.0%) | $333.60 K(-12.1%) |
| Sept 2023 | - | $66.20 K(-51.9%) | $379.50 K(-9.1%) |
| June 2023 | - | $137.70 K(+73.4%) | $417.30 K(+7.1%) |
| Mar 2023 | - | $79.40 K(-17.5%) | $389.60 K(-10.4%) |
| Dec 2022 | $434.60 K(-19.8%) | $96.20 K(-7.5%) | $434.60 K(-35.3%) |
| Sept 2022 | - | $104.00 K(-5.5%) | $671.80 K(+6.2%) |
| June 2022 | - | $110.00 K(-11.6%) | $632.70 K(+6.3%) |
| Mar 2022 | - | $124.40 K(-62.7%) | $595.10 K(+9.8%) |
| Dec 2021 | $542.00 K(+84.2%) | $333.40 K(+413.7%) | $542.00 K(+71.2%) |
| Sept 2021 | - | $64.90 K(-10.4%) | $316.50 K(+1.2%) |
| June 2021 | - | $72.40 K(+1.5%) | $312.70 K(+3.1%) |
| Mar 2021 | - | $71.30 K(-33.9%) | $303.40 K(+3.2%) |
| Dec 2020 | $294.20 K(-8.5%) | $107.90 K(+76.6%) | $294.10 K(+14.7%) |
| Sept 2020 | - | $61.10 K(-3.2%) | $256.30 K(-2.5%) |
| June 2020 | - | $63.10 K(+1.8%) | $262.80 K(-11.5%) |
| Mar 2020 | - | $62.00 K(-11.6%) | $297.00 K(-7.7%) |
| Dec 2019 | $321.70 K(-28.7%) | $70.10 K(+3.7%) | $321.80 K(-5.8%) |
| Sept 2019 | - | $67.60 K(-30.5%) | $341.60 K(-9.1%) |
| June 2019 | - | $97.30 K(+12.1%) | $375.70 K(-8.1%) |
| Mar 2019 | - | $86.80 K(-3.4%) | $409.00 K(-9.4%) |
| Dec 2018 | $451.30 K(-16.3%) | $89.90 K(-11.6%) | $451.30 K(-7.7%) |
| Sept 2018 | - | $101.70 K(-22.1%) | $488.70 K(-5.6%) |
| June 2018 | - | $130.60 K(+1.2%) | $517.80 K(-2.2%) |
| Mar 2018 | - | $129.10 K(+1.4%) | $529.40 K(-1.8%) |
| Dec 2017 | $539.30 K(-36.5%) | $127.30 K(-2.7%) | $539.30 K(-4.0%) |
| Sept 2017 | - | $130.80 K(-8.0%) | $561.60 K(-12.9%) |
| June 2017 | - | $142.20 K(+2.3%) | $644.50 K(-13.6%) |
| Mar 2017 | - | $139.00 K(-7.1%) | $746.20 K(-12.2%) |
| Dec 2016 | $849.60 K | $149.60 K(-30.0%) | $849.50 K(-10.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2016 | - | $213.70 K(-12.4%) | $949.80 K(-6.4%) |
| June 2016 | - | $243.90 K(+0.7%) | $1.02 M(-7.2%) |
| Mar 2016 | - | $242.30 K(-3.0%) | $1.09 M(-6.1%) |
| Dec 2015 | $1.17 M(+48.3%) | $249.90 K(-10.5%) | $1.17 M(-3.4%) |
| Sept 2015 | - | $279.10 K(-13.4%) | $1.21 M(-3.7%) |
| June 2015 | - | $322.40 K(+2.7%) | $1.25 M(+20.0%) |
| Mar 2015 | - | $313.80 K(+7.9%) | $1.04 M(+32.8%) |
| Dec 2014 | $785.80 K(+125.4%) | $290.80 K(-10.6%) | $785.80 K(+35.5%) |
| Sept 2014 | - | $325.20 K(+186.8%) | $580.00 K(+68.6%) |
| June 2014 | - | $113.40 K(+101.1%) | $344.00 K(+6.6%) |
| Mar 2014 | - | $56.40 K(-33.6%) | $322.60 K(-7.5%) |
| Dec 2013 | $348.70 K(+13.1%) | $85.00 K(-4.7%) | $348.60 K(+3.6%) |
| Sept 2013 | - | $89.20 K(-3.0%) | $336.50 K(+3.0%) |
| June 2013 | - | $92.00 K(+11.7%) | $326.80 K(+4.3%) |
| Mar 2013 | - | $82.40 K(+13.0%) | $313.30 K(+1.6%) |
| Dec 2012 | $308.40 K(+20.8%) | $72.90 K(-8.3%) | $308.40 K(+0.9%) |
| Sept 2012 | - | $79.50 K(+1.3%) | $305.80 K(+5.9%) |
| June 2012 | - | $78.50 K(+1.3%) | $288.70 K(+6.4%) |
| Mar 2012 | - | $77.50 K(+10.2%) | $271.40 K(+6.4%) |
| Dec 2011 | $255.20 K(+51.6%) | $70.30 K(+12.7%) | $255.10 K(+19.6%) |
| Sept 2011 | - | $62.40 K(+2.0%) | $213.30 K(+13.1%) |
| June 2011 | - | $61.20 K(0.0%) | $188.60 K(+5.4%) |
| Mar 2011 | - | $61.20 K(+114.7%) | $179.00 K(+6.4%) |
| Dec 2010 | $168.30 K(+9.1%) | $28.50 K(-24.4%) | $168.30 K(-11.8%) |
| Sept 2010 | - | $37.70 K(-26.9%) | $190.80 K(+7.5%) |
| June 2010 | - | $51.60 K(+2.2%) | $177.50 K(+6.7%) |
| Mar 2010 | - | $50.50 K(-1.0%) | $166.40 K(+8.0%) |
| Dec 2009 | $154.20 K(+17.7%) | $51.00 K(+109.0%) | $154.10 K(+49.5%) |
| Sept 2009 | - | $24.40 K(-39.8%) | $103.10 K(+31.0%) |
| June 2009 | - | $40.50 K(+6.0%) | $78.70 K(+106.0%) |
| Mar 2009 | - | $38.20 K | $38.20 K |
| Dec 2008 | $131.00 K | - | - |
FAQ
- What is China Pharma Holdings annual interest expense?
- What is the all time high annual interest expense for China Pharma Holdings?
- What is China Pharma Holdings annual interest expense year-on-year change?
- What is China Pharma Holdings quarterly interest expense?
- What is the all time high quarterly interest expense for China Pharma Holdings?
- What is China Pharma Holdings quarterly interest expense year-on-year change?
- What is China Pharma Holdings TTM interest expense?
- What is the all time high TTM interest expense for China Pharma Holdings?
- What is China Pharma Holdings TTM interest expense year-on-year change?
What is China Pharma Holdings annual interest expense?
The current annual interest expense of CPHI is $333.60 K
What is the all time high annual interest expense for China Pharma Holdings?
China Pharma Holdings all-time high annual interest expense is $1.17 M
What is China Pharma Holdings annual interest expense year-on-year change?
Over the past year, CPHI annual interest expense has changed by -$101.00 K (-23.24%)
What is China Pharma Holdings quarterly interest expense?
The current quarterly interest expense of CPHI is $34.10 K
What is the all time high quarterly interest expense for China Pharma Holdings?
China Pharma Holdings all-time high quarterly interest expense is $333.40 K
What is China Pharma Holdings quarterly interest expense year-on-year change?
Over the past year, CPHI quarterly interest expense has changed by -$32.10 K (-48.49%)
What is China Pharma Holdings TTM interest expense?
The current TTM interest expense of CPHI is $174.70 K
What is the all time high TTM interest expense for China Pharma Holdings?
China Pharma Holdings all-time high TTM interest expense is $1.25 M
What is China Pharma Holdings TTM interest expense year-on-year change?
Over the past year, CPHI TTM interest expense has changed by -$204.80 K (-53.97%)